semaglutide mash fda approval Wegovy Gets F.D.A. for Wegovy (semaglutide 2.4 mg) approved

, D'Agostino, G

After 28 days, a reduction in wrinkles of 80% to 93% was measured

Discov Med 2004

Although interventions such as antihypertensive therapy and valve replacement can resolve chronic cardiac injury, they often fail to reverse the myocardial fibrosis process, suggesting that the fibrogenic process may become self-sustaining

The mechanism was proposed to involve copper-dependent enzymes (notably lysyl oxidase, which catalyzes the cross-linking of collagen and elastin and requires copper as a cofactor), GHK-specific effects on growth factor activity, and downstream gene-expression effects in fibroblasts and other tissue-repair-relevant cell types